The Moderna trial involved tens of thousands of participants, not five! Five of the people who were given the vaccine developed Covid, compared to 95 people who'd been given the placebo. So 94.5% of the people in the trial who would probably have developed Covid normally were protected by the vaccine. (You'd have expected 95 to catch it, just like in the placebo group, but only 5 did, so 90 out of 95 were protected)
The odd thing is, only 0.3% of people in the survey developed symptoms - do we know the time period, I assume a number of months, and to be eligible you're going to be an adult 18-60 ? The prevalence of coronavirus in the UK over the last 3 months among that age group has been well over 6%. That means we'd've expected 1-2% to have symptoms, but the vaccinated population was 0.3% - this was tested in a very low prevalence population, which seems odd.